Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E

Luisa A. Ikner, Jason R. Torrey, Patricia M. Gundy, Charles P. Gerba
doi: https://doi.org/10.1101/2020.05.10.20097329
Luisa A. Ikner
1Department of Environmental Science, Center for Water, Environment and Sustainable Technology, University of Arizona, Tucson, AZ 85721
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason R. Torrey
1Department of Environmental Science, Center for Water, Environment and Sustainable Technology, University of Arizona, Tucson, AZ 85721
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia M. Gundy
1Department of Environmental Science, Center for Water, Environment and Sustainable Technology, University of Arizona, Tucson, AZ 85721
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles P. Gerba
1Department of Environmental Science, Center for Water, Environment and Sustainable Technology, University of Arizona, Tucson, AZ 85721
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gerba@ag.arizona.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The disinfection of high-contact surfaces is seen as an infection control practice to prevent the spread of pathogens by fomites. Unfortunately, recontamination of these surfaces can occur any time after the use of common disinfectants. We recently reported on a novel continuously active antimicrobial coating which was shown to reduce the spread of healthcare acquired infections in hospitals. We evaluated a modified coating that demonstrated a residual efficacy against viruses. The coated surfaces were found to be effective against human coronavirus (HCoV) 229E, reducing the concentration of these viruses by greater than 90% in 10 minutes and by greater than 99.9% after two hours of contact. The coating formulation when tested in suspension yielded a greater than 99.99% reduction of HCoV 229E within ten minutes of contact. This outcome presents an opportunity for controlling the transmission of COVID-19 from contaminated fomites.

Competing Interest Statement

This project was funded by Allied Biosciences to the University of Arizona, whose researchers participated in the study design. The conduct of the study, analysis, and presentation of the results as well as the decision to publish were solely determined by the authors without influence by the funding source.

Funding Statement

This project was funded by a grant from Allied Biosciences to the University of Arizona,

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data and calculations for each experiment can be provided

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 13, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E
Luisa A. Ikner, Jason R. Torrey, Patricia M. Gundy, Charles P. Gerba
medRxiv 2020.05.10.20097329; doi: https://doi.org/10.1101/2020.05.10.20097329
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E
Luisa A. Ikner, Jason R. Torrey, Patricia M. Gundy, Charles P. Gerba
medRxiv 2020.05.10.20097329; doi: https://doi.org/10.1101/2020.05.10.20097329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1425)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (585)
  • Epidemiology (10306)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2636)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1739)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (267)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1326)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (237)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2404)
  • Public and Global Health (5018)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)